Wade Walke | IR |
Stan Crooke | CEO |
Beth Hougen | CFO |
Sarah Boyce | President of Akcea Therapeutics |
Brett Monia | COO |
Damien McDevitt | Chief Business Officer |
Chad Messer | Needham & Company |
Tyler Van Buren | Piper Jaffray |
Jim Birchenough | Wells Fargo Securities |
Ritu Baral | Cowen & Company |
Yale Jen | Laidlaw & Company |
Good morning and welcome to the Ionis Pharmaceuticals Second Quarter 2018 Financial Results Conference Call.
As a reminder, this call is being recorded. At this time, I would like to turn the conference over to Wade Walke, Vice President of Investor Relations to lead off the call. Sir, you may begin.
Thank you, Cole.